Abstract
Angeborene Stoffwechselstörungen des Aminosäurestoffwechsels zählen zur Gruppe der seltenen Erkrankungen. Abhängig vom Stoffwechseldefekt können sie unbehandelt zu schweren psychomotorischen Störungen oder zu lebensbedrohlichen metabolischen Entgleisungen führen. Mit frühzeitiger Diagnosestellung und zügigem Therapiebeginn können diagnoseabhängig die Symptome gemildert oder vollständig vermieden werden. In many cases, inborn errors of the amino acid metabolism can be treated by diet, either partial or exclusive. Phenylketonuria (PKU) is the most frequent inherited metabolic disease of the amino acid-metabolism. Untreated, PKU leads to microcephaly including severe mental retardation and strong impaired psychomotor development. PKU is detected by newborn screening. Due to an early initiation of the continuously lifelong Phe-restricted diet with supplementation of amino acids and micronutrients patients develop like healthy children. Tyrosinemia type 1 is an inborn error of tyrosine metabolism. Since April 2018 tyrosinemia type 1 is included in the German newborn screening program. Clinically patients can be noticed by growth retardation, oversize liver, tendency to bleed, soft and weak bones. Accelerated succinylacetone in urine confirms the diagnoses. Therapy consists of a pharmacological treatment with NTBC (2-(2-Nitro-4-Trifluoromethylbenzoyl)-1,3-Cyclohexanedion, Orfadin®), which helps to reduce toxic alternative metabolites. Additionally, a tyrosine restricted diet can be necessary. Urine cycle disorders can be life-threatening. Symptoms are unspecific, remind on intoxication and are easily overseen. For differential diagnosis ammonia has to be determined. Therapy is a combination of medication and diet. Protein has to be reduced to the minimum. Citrulline and arginine are able to start up the urine cycle; Na-butyrat can detox amino groups.

This publication has 10 references indexed in Scilit: